|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5723459A
(en)
|
1991-05-09 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
Biologically active acylated amino acid derivatives
|
|
US5844001A
(en)
|
1993-02-26 |
1998-12-01 |
Research Development Foundation |
Combination platinum chemotherapeutic/antiestrogen therapy for human cancers
|
|
FR2757866B1
(fr)
|
1996-12-30 |
2004-12-17 |
Catalyse |
Polymeres comportant des groupes ammoniums quaternaires, leur utilisation pour la fabrication d'un materiau a propretes antibacteriennes et leurs procedes de preparation
|
|
US6403765B1
(en)
|
1998-06-16 |
2002-06-11 |
Thomas Jefferson University |
Truncated Apaf-1 and methods of use thereof
|
|
AU5205499A
(en)
|
1998-07-27 |
2000-02-21 |
Pharmacia & Upjohn Company |
Method for autoactivation of procaspase 8
|
|
US6110691A
(en)
|
2000-01-06 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Activators of caspases
|
|
US6608026B1
(en)
|
2000-08-23 |
2003-08-19 |
Board Of Regents, The University Of Texas System |
Apoptotic compounds
|
|
AU2002211602A1
(en)
|
2000-10-11 |
2002-04-22 |
Johns Hopkins University |
Polymer controlled delivery of a therapeutic agent
|
|
WO2002048329A2
(en)
|
2000-11-20 |
2002-06-20 |
Idun Pharmaceuticals, Inc. |
Membrane derived caspase-3, compositions comprising the same and methods of use therefor
|
|
US6878743B2
(en)
|
2001-09-18 |
2005-04-12 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
WO2004066958A2
(en)
|
2003-01-30 |
2004-08-12 |
The Trustees Of Princeton University |
Caspase-9:bir3 domain of xiap complexes and methods of use
|
|
US7632972B2
(en)
|
2003-10-30 |
2009-12-15 |
The Board Of Trustees Of The University Of Illionis |
Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
|
|
CN1889958A
(zh)
|
2003-12-09 |
2007-01-03 |
美国政府健康及人类服务部 |
抑制免疫应答或治疗增生性疾病的方法
|
|
US8440610B2
(en)
|
2004-11-12 |
2013-05-14 |
Massachusetts Institute Of Technology |
Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
|
|
CN101184491A
(zh)
|
2005-05-26 |
2008-05-21 |
伊利诺伊大学评议会 |
包括活化半胱天冬酶-3酶原的癌细胞内选择性细胞凋亡诱导
|
|
WO2008134474A2
(en)
|
2007-04-27 |
2008-11-06 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods including cell death inducers and procaspase activation
|
|
US20070049602A1
(en)
|
2005-05-26 |
2007-03-01 |
The Board Of Trustees Of The University Of Illinois |
Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3
|
|
RU2408584C2
(ru)
|
2005-06-23 |
2011-01-10 |
Мерк Шарп Энд Домэ Корп. |
Ингибиторы тирозинкиназы
|
|
WO2007008926A1
(en)
|
2005-07-11 |
2007-01-18 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
|
TWI373473B
(en)
|
2005-09-02 |
2012-10-01 |
Otsuka Pharma Co Ltd |
Anticancer agent
|
|
AR056517A1
(es)
|
2005-09-16 |
2007-10-10 |
Schering Corp |
Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa
|
|
US20070111936A1
(en)
|
2005-11-15 |
2007-05-17 |
Vladimir Pak |
Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
|
|
US7709465B2
(en)
|
2006-05-19 |
2010-05-04 |
The Board Of Trustees Of The University Of Illinois |
Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
PH12013501594A1
(en)
|
2007-07-20 |
2014-05-12 |
Nerviano Medical Sciences Srl |
Substituted indazole derivatives active as kinase inhibitors
|
|
RU2360692C1
(ru)
|
2007-12-21 |
2009-07-10 |
Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) |
Средство, стимулирующее апоптоз клеток лейкемии человека
|
|
CN101965189A
(zh)
|
2008-01-11 |
2011-02-02 |
加利福尼亚大学董事会 |
处决胱冬酶原3、6和7的激活剂
|
|
US20100291214A1
(en)
|
2008-12-23 |
2010-11-18 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
AU2010210404A1
(en)
|
2009-02-09 |
2011-08-25 |
St. Jude Medical, Cardiology Division, Inc. |
Inflatable minimally invasive system for delivering and securing an annular implant
|
|
AU2010210403B2
(en)
|
2009-02-09 |
2016-07-28 |
The Board Of Trustees Of The University Of Illinois |
Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
|
|
AU2010247800A1
(en)
|
2009-05-11 |
2011-12-15 |
Berg Llc |
Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
|
|
CA2763471A1
(en)
|
2009-05-27 |
2010-12-02 |
Cephalon, Inc. |
Combination therapy for the treatment of multiple myeloma
|
|
WO2010151746A2
(en)
|
2009-06-26 |
2010-12-29 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
TWI386203B
(zh)
|
2011-01-07 |
2013-02-21 |
Univ China Medical |
治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
|
|
WO2012118978A1
(en)
|
2011-03-03 |
2012-09-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treating oncovirus positive cancers
|
|
US20140348819A1
(en)
|
2011-06-24 |
2014-11-27 |
Dana-Farber Cancer Institute, Inc. |
Methods of Treating Cancer
|
|
CN103702990B
(zh)
*
|
2011-07-27 |
2015-09-09 |
阿斯利康(瑞典)有限公司 |
2-(2,4,5-取代苯胺)嘧啶衍生物作为egfr调谐子用于治疗癌症
|
|
US8916705B2
(en)
|
2011-10-14 |
2014-12-23 |
The Board of Trustees of The University of Illilnois |
Procaspase-activating compounds and compositions
|
|
US9592229B2
(en)
|
2012-03-02 |
2017-03-14 |
The Board Of Trustees Of The University Of Illinois |
Potent anticancer activity via dual compound activation
|
|
DK2822558T3
(da)
|
2012-03-06 |
2020-03-23 |
The Board Of Trustees Of The Univ Of Illionis |
Procaspase 3 aktivering ved hjælp af kombinations terapi
|
|
CA2866020C
(en)
|
2012-03-06 |
2020-09-22 |
The Board Of Trustees Of The University Of Illinois |
Procaspase combination therapy for glioblastoma
|
|
EP2880020B1
(en)
|
2012-08-03 |
2018-11-28 |
The Board of Trustees of the University of Illionis |
Enzyme-activating compounds and compositions
|
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
|
JP6835472B2
(ja)
|
2013-03-05 |
2021-02-24 |
ユニバーシティ オブ テネシー リサーチ ファウンデーション |
癌の処置のための組成物
|
|
JP6720075B2
(ja)
|
2013-05-31 |
2020-07-08 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
癌のための併用療法
|
|
CN105530931B
(zh)
|
2013-07-12 |
2019-11-08 |
皮拉马尔企业有限公司 |
用于治疗黑素瘤的药物组合
|
|
GB201320302D0
(en)
*
|
2013-11-18 |
2014-01-01 |
Element Six Ltd |
Diamond components for quantum imaging sensing and information processing devices
|
|
DK3302478T3
(da)
|
2015-06-05 |
2022-02-14 |
The Board Of Trustees Of The Univ Of Illionis |
Pac-1 kombinations behandling
|
|
BR112018012255A2
(pt)
|
2015-12-18 |
2018-12-04 |
Ignyta Inc |
método para tratar câncer
|
|
WO2018106595A1
(en)
|
2016-12-05 |
2018-06-14 |
Fate Therapeutics, Inc. |
Compositions and methods for immune cell modulation in adoptive immunotherapies
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
SG11202004384YA
(en)
*
|
2017-11-17 |
2020-06-29 |
Univ Illinois |
Cancer therapy by degrading dual mek signaling
|